Endoclear
Petoskey, US
Founders & leadership
KW
Ken WatsonExecutive
BV
Brad VazalesExecutive
DC
David CherskyDavid Chersky serves as Vice President of Operations.
GK
Greg KapustGreg Kapust is the Executive Chairman of the Board.
JH
Jay HerefordExecutive
GS
Gary SauerGary Sauer, MBA, RRT is Director of Clinical Affairs.
Reported raises · per SEC filings
Form D private placements$782.8K disclosed across 1 round · 2014
▶$782.8KraisedMay 2014 · 63 investors · Other Health CareRule 506(b)
▶$782.8KraisedMay 2014 · 63 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ken WatsonExecutive Officer, Director
- Brad VazalesExecutive Officer, Director
- David CherskyExecutive Officer
- Gary SauerExecutive Officer
- Greg KapustDirector
- Jay HerefordExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $782.8K
- First sale
- May 2014
- Incorporated
- Limited Liability Company, Michigan
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Endoclear raised?
- Endoclear has disclosed $782.8K raised across 1 round.
- Where is Endoclear headquartered?
- Endoclear is headquartered in Petoskey, US.